Effects of High White and Brown Sugar Consumption on Serum Level of Brain-Derived Neurotrophic Factor, Insulin Resistance, and Body Weight in Albino Rats.

BACKGROUND: In recent decades, consumption of simple sugars has increased dramatically, which contributes to health problems including insulin resistance and obesity. In this study, we investigated the effects of high concentrations of white sugar (WS) and brown sugar (BS) on serum concentration of brain-derived neurotrophic factor (BDNF), insulin resistance, and body weight in albino rats.
METHODS: Twenty-four male Wistar rats were randomly divided into three groups: control, a group treated with 15% WS, and a group treated with 15% BS. Rats were given WS and BS by gavage (daily) for 42 days. At the end of the intervention period, serum level of BDNF, insulin resistance, and body weight were measured.
RESULTS: Body weight and insulin resistance were significantly increased and serum BDNF level was decreased in both WS and BS groups compared to the control group (P<0.05). In the WS-treated rats, the amount of changes in the insulin resistance, body weight, and serum BDNF level was greater compared to that in BS-treated (P< 0.05).
CONCLUSION: Due to the adverse effects of consuming high levels of WS and BS on serum level of BDNF, insulin resistance, and body weight, high intakes of these sweeteners are not recommended.

INTRODUCTION

In recent decades, consumption of sugars has increased rapidly, with negative effects on human health.[1] Excessive consumption of sweetened beverages causes metabolic diseases such as type 2 diabetes mellitus (T2DM), obesity, and cardiovascular diseases.[2] The World Health Organization (WHO) recommends that the daily consumption of sugars not be greater than 5%–10% of the overall daily caloric intake.[3] Problems associated with high consumption of simple sugars are obesity and, consequently, insulin resistance.[2] Insulin resistance has on inverse effect on serum level of brain-derived neurotrophic factor (BDNF).[4]

BDNF is one of the factors of the neurotrophin family that is widely secreted in some areas of mammalian cerebral tissue, such as the hippocampal region.[5] BDNF plays a vital role in development and maintenance of central and peripheral nervous system health and synaptic plasticity.[4] Serum level of BDNF has been reported to decrease in patients with insulin resistance and diabetes.[4] A common belief exists that brown sugar (BS) is less damaging to health than white sugar (WS), but preliminary experimental information on this matter is scarce. The purpose of this study was to investigate the effects of high WS and BS consumption on serum level of BDNF, insulin resistance, and body weight in albino rats.

METHODS

In this experimental study, 24 healthy male Wistar rats, aged 3 months and weighing 200–250 g, were purchased from the laboratory of the animal research center of Zahedan University of Medical Sciences. All stages of the study were designed and implemented according to the guidelines of the laboratory animal ethics committee of Zahedan University of Medical Sciences (No. IR.ZAUMS.REC.1398.448). The rats were exposed to dark/light cycles and allowed free access to diet and water. The environmental temperature was kept at 24°C±2°C with 60%±5% humidity. The intervention was started after 2 weeks of acclimatization.[6]

Solution preparation

The percentages of sugar solutions were calculated based on the daily caloric intake of rats (15–16 g). According to the WHO recommendation that healthy people should not consume more than 5% of their daily calories as sugar, 15% of the daily caloric intake of rats was determined to be 2.25 g. For each of the sugar groups, the concentration of total sugar in solution was 2.25 g wt: vol (comparable to sugar-sweetened beverages [SSBs] typically consumed by humans) in distilled water.

Experimental design and dietary regimen

The rats were divided into three equal groups (eight rats per each group) including:[7] group 1, control group; group 2: group treated with 15% of WS; group 3, group treated with 15% of BS. Rats had free access to water and food. The control group received normal saline, and the intervention groups received WS or BS (Haft Tapeh Sugar Cane Company, Ahvaz, Iran) by oral gavage (daily) for 42 days.[8]

Collecting samples

At the end of the experimental period, the rats were anesthetized with 60 mg/kg of ketamine and 5 mg/kg of xylazine (Alfasan, Woerden, the Netherlands) after 12 hours of overnight fasting.[6] Blood samples were collected through cardiac puncture for determination of biochemical parameters. Blood samples were centrifuged at 3,000 rpm for 10 minutes to obtain serum. The serum samples were isolated in special micro-tubes and frozen at –75°C until biochemical assessments.[6] At the beginning and end of the intervention, body weight was measured using a digital scale (EK610i; A&D, Tokyo, Japan). At the end of the intervention, the rats were anesthetized with an intraperitoneal injection of a mixture of ketamine/xylazine for euthanasia.

Plasma biochemical assays

Serum levels of insulin and BDNF (Bioassay Technology Laboratory, Shanghai, China) were measured using rat-specific kits by enzyme-linked immunosorbent assay (ELISA) using an ELISA reader (Stat Fax 2100; Awareness Technology, Palm City, FL, USA).[9]

Estimation of insulin resistance

The homeostatic model assessment for insulin resistance (HOMA-IR) formula was used to estimate insulin resistance.[10]

Statistical analysis

Statistical analysis was performed using GraphPad Prism version 8.0 (GraphPad, San Diego, CA, USA). The Kolmogorov-Smirnov test was utilized to test data required for various assessments of normal distribution. If the distribution was normal, data were presented as mean±standard error of the mean. HOMA-IR and BDNF were analyzed at the end of the intervention using one-way analysis of variance (ANOVA) after applying Tukey’s post hoc test. Body weight data were analyzed by repeated one-way ANOVA followed by Tukey’s post-hoc test. The P-values <0.05 were considered significant.

RESULTS

Effects of WS and BS consumption on rat body weight

The effects of WS and BS consumption on body weight were measured before and after of the intervention. Excessive consumption of WS and BS significantly increased body weight in the intervention groups compared to the control group at the end of the intervention (P<0.05). Interestingly, WS caused greater increase in body weight than BS, and this difference was significant (P<0.05). These differences were not significant before the intervention.

Effects of WS and BS consumption on insulin resistance in rats

The effects of WS and BS consumption on HOMA-IR were measured at the end of the intervention and are shown in Fig. 1. HOMA-IR values were significantly increased in both WS and BS compared with the control group (P<0.05).

Figure. 1

Effects of white and brown sugar consumption on insulin resistance in rats. Values are presented as mean± standard deviation (n= 8) and analyzed by one-way analysis of variance and Tukey’s post-hoc tests. *P<0.001 compared to the Con group; †P<0.001 compared to the BS group. HOMA-IR, homeostatic model assessment for insulin resistance; Con, control; BS, brown sugar; WS, white sugar.

Effects of WS and BS consumption on serum level of BDNF in the rats

The effects of WS and BS consumption on serum level of BDNF were measured at the end of the intervention and are shown in Fig. 2. The serum level of BDNF in WS and BS groups was significantly decreased compared to that of the control group (P<0.05), and mean BDNF concentration in the WS group was less than that in the BS group (P<0.05).

Figure. 2

Effects of white and brown sugar consumption on serum level of BDNF in rats Values are presented as mean± standard deviation (n= 8) and analyzed by one-way analysis of variance and Tukey’s post-hoc tests. *P<0.001 compared to the Con group; †P<0.001 compared to the BS group. BDNF, brain-derived neurotrophic factor; Con, control; BS, brown sugar; WS, white sugar.

DISCUSSION

In our study, the effects of high consumption of WS and BS on serum level of BDNF, insulin resistance, and body weight in Wistar rats were investigated. We found that body weight and HOMA-IR were significantly increased in the WS and BS groups in comparison with the control group. Zhao and Castonguay[11] reported that long-term consumption of sugar can increase the risk of obesity and other associated diseases. Lozano et al.[12] investigated whether a high fructose and high-fat diet can increase the risk of diabetes and its complications and showed that 2 months of consumption of a high fructose and high-fat diet can cause increases in body weight and HOMA-IR. Gómez-Crisóstomo et al.[8] conducted a study to investigate the effects of high-calorie diets on insulin sensitivity in rats and showed that 1-week consumption of solution containing 30% sugar had little effect on insulin sensitivity. These results indicate that development of insulin resistance depends on the amount of sugar in solution and the duration of the intervention. The harmful effects of SSBs may be explained by de novo lipogenesis, resulting in weight gain and fat accumulation in the abdomen.[13] Consumption of SSBs may also aggravate inflammation and insulin resistance by altering expression of related genes, such as interleukin-6 and monocyte chemoattractant protein-1.[14]

In our experimental study, we found that serum level of BDNF in WS and BS groups was significantly decreased compared to that in the control group. The WS group exhibited greater weight gain compared to the BS group, explaining the differences in HOMA-IR and BDNF between WS and BS. To explain how diet may impact neural plasticity, studies have shown that obesity reduces the concentration and function of BDNF, and that high sugar diets can enhance the production of free radicals in the liver and brain. Neurotrophic factors such as BDNF protect neurons against oxidative stress, and the high-fat sucrose diet can attenuate neurotransmitter secretion that is typically modulated by BDNF and synapsin 1.[4] Insulin resistance reduces the expression of BDNF in sensory and motor roots.[15] BDNF concentration is also decreased in the plasma of T2DM patients. Therefore, there is an inverse correlation between BDNF and fasting plasma glucose/HOMA-IR index.[16]

Chromium is an element that plays a role in improving insulin sensitivity. There is three times as much of this element in BS as in WS.[8] Therefore, WS is more effective than BS for increasing HOMA-IR and decreasing serum level of BDNF.[8] In this context, Feng et al.[17] reported that chromium malate improved glucose metabolism in diabetic rats. Another reason that BS more effectively lowers HOMA-IR than does WS is due to its high antioxidant values.[8]

Finally, we conclude that excessive consumption of WS and BS has negative effects on serum level of BDNF, insulin resistance, and body weight. The negative effects of BS on these factors are less than those of WS. We also recommend that future research examine the effects of different doses of WS and BS intake on biochemical factors in healthy and diabetic albino rats. Histology phenotypes (liver, adipose, muscle, brain) and immunohistochemistry were not identified in this study.